4//SEC Filing
Irish Stephanie Rast 4
Accession 0001209191-09-025193
CIK 0001347178other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 6:28 PM ET
Size
6.4 KB
Accession
0001209191-09-025193
Insider Transaction Report
Form 4
Irish Stephanie Rast
Sr. VP, Acting CFO/Treasurer
Transactions
- Award
Restricted Stock Units
2009-05-06+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested upon the Issuer's receipt of approval by the United States Food & Drug Administration of its New Drug Application for Fanapt(TM)(iloperidone) on May 6, 2009.
- [F2]N/A
- [F3]On January 20, 2009, the Reporting Person filed a Form 3 which stated that the Reporting Person owned 40,000 shares of Restricted Common Stock which had not vested as of such date. The 20,000 Restricted Stock Units reported herein were included in such aggregate number of securities reported as being owned by the Reporting Person.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001454241
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 6:28 PM ET
- Size
- 6.4 KB